.We currently recognize that Takeda is expecting to discover a road to the FDA for epilepsy medicine...
.Immunology biotech VBI Vaccinations is actually drifting precariously close to the defining moment,...
.It's not easy to muscular tissue in on a space as competitive as immunology, yet Celldex Therapeuti...
.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Rehabs and also a preclinical invulne...
.Ventyx Biosciences' Crohn's illness medicine did certainly not help patients accomplish remission i...
.Cognition Therapies' phase 2 sparkle trial has actually taken a few of the luster off the Alzheimer...
.Bristol Myers Squibb has had a whiplash change of mind on its own BCMA bispecific T-cell engager, s...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squibb...
.After reaching out to more than 200 companies to partner a Tourette disorder therapy that revealed ...
.Novartis has had some misfortune along with bispecific antitoxins before, yet determining by the ph...